A minimum 2:1 honours degree (or equivalent) in the biomedical sciences. International candidates must have obtained the equivalent of a 2:1 in a related degree from a reputed University. Candidates on the undergraduate medical programme must have satisfactorily completed years 1-4 of the MBChB with no failure at any examination.
Pharmaceutical Cancer; Interdisciplinary Molecular Medicine
Months of entry
Translational Medicine is driven by the objective of improving clinical outcomes from molecular and cellular discoveries to the benefit of the patient. Enhancing bench-to-bedside research encourages faster throughput of basic science to applied clinical care and is, therefore, of critical importance to the development of healthcare delivery.
The MRes is a pioneering new course aimed at training high calibre bioscientists in this emerging discipline.
The course is based in the new Manchester Interdisciplinary Biocentre, a world-class facility aiming to promote interdisciplinary bioscience at the highest international level. Industry directed training is also provided through AstraZeneca.
Information for international students
Candidates whose first language is not English require a minimum of IELTS 6.5 or TOEFL 575 paper-based or 230 computer-based.
Fees and funding
Studentships for UK/EU nationals are provided by AstraZeneca and Cancer Research UK (CRUK).
Qualification and course duration
Course contact details
- Dr Philip Padfield
- +44 (0) 161 275 1820